EP3076971
Efnasamsetningar og aðferðir við að draga úr alvarlegum meintilvikum á hjarta- og æðakerfi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.12.2014EP published:
20.10.2021EP application number:
14867191.0
EP translation filed:
18.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
3.12.2034Expiry date:
3.12.2026Next due date:
31.12.2026
Title:
COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS
Timeline
Today
4.12.2014EP application
20.10.2021EP Publication
18.1.2022Translation submitted
15.2.2022Registration published
3.12.2026Expires
Owner
Name:
Nalpropion Pharmaceuticals LLCAddress:
155 Franklin Rd, Suite 450, Brentwood, TN 37027, US
Inventor
Name:
KLASSEN, PrestonAddress:
La Jolla, CA 92037, US
Name:
TAYLOR, KristinAddress:
San Diego, CA 92127, US
Agent
Name:
Lára Helga SveinsdóttirAddress:
Grundarstíg 23, 101, Reykjavík,
Priority
Number:
201361913216 PDate:
6.12.2013Country:
US
Number:
201361914938 PDate:
11.12.2013Country:
US
Number:
201461984580 PDate:
25.4.2014Country:
US
Number:
201414322810Date:
2.7.2014Country:
US
Classification
Categories:
A61P 9/10, A61K 31/485, A61K 31/137
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 24.1.2022
Expires: 3.12.2022
Payer: Lára Helga Sveinsdóttir
Number: 9
Paid: 30.11.2022
Expires: 3.12.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.11.2023
Expires: 3.12.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.11.2024
Expires: 3.12.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.12.2025
Expires: 3.12.2026
Payer: Árnason Faktor ehf.